Key facts
- This page summarizes John Strahley's Form 4/A - Amendment filing for Aspira Women's Health Inc. (AWHL).
- 1 reported transaction and 1 derivative row are listed below.
- Accepted by SEC: 17 Jul 2026, 18:33.
John Strahley - 16 Jun 2026 Form 4/A - Amendment Insider Report for Aspira Women's Health Inc. (AWHL)
- Reporting relationship
- Chief Financial Officer
- Issuer ticker
- AWHL
- Reported as of
- 16 Jun 2026
- Net transaction value
- $0
- SEC form
- 4/A - Amendment
- Accepted by SEC
- 17 Jul 2026, 18:33:23 UTC
- Original report date
- 15 Jul 2026
- Prior SEC filing
- 15 Jul 2026
- Source filing
- View source filing
- Reporting owner signature
- /s/ John Strahley
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
John Strahley filed Form 4/A - Amendment for Aspira Women's Health Inc. (AWHL) on 17 Jul 2026.
Change
- Previous filing in this sequence was filed on 15 Jul 2026.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4/A - Amendment disclosures.
Reporting Owners (1)
CIK 0001875425
Primary reporting owner
Strahley John
- Relationship
- Chief Financial Officer
- Address
- C/O ASPIRA WOMEN'S HEALTH INC., 12117 BEE CAVES RD, BLDG 3-100, AUSTIN
- Signature
- /s/ John Strahley
- Signature date
- 17 Jul 2026
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
AWHL
transaction
Derivative
Employee Stock Option (Right to Buy)
Award
- Transaction value
- Shares
- +70,000
- Change %
- Price
- $0.000000*
- Shares after
- 70,000
- Date
- 16 Jun 2026
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 70,000
- Exercise price
- $0.5000
- Footnotes
- F1, F2
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 2 footnotes
Footnote F1
This form is being filed to correct the number of options awarded.
Footnote F2
17,500 shares will vest on July 26, 2026. The remaining shares will vest in equal monthly installments over the next 9 months.